News
The AMoRE experimental collaboration in South Korea has reported not finding evidence of neutrinoless double beta decay after a two-year search, imposing stringent limits on this mysterious, ...
Thus the elements uranium X” ionium, and radio-actinium are istopic ... any given number of electrons may assume different configurations it is possible for two or more elements to exist ...
NEW YORK, NY / ACCESS Newswire / April 19, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want ...
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) between October 31, 2022 and August 2, 2024 ...
For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that Actinium Pharmaceuticals ...
Actinium Pharmaceuticals, Inc., a pioneer in the development of targeted radiotherapies, announced it has entered into an agreement for the supply of Actinium-225 (Ac-225) with Eckert & Ziegler. Under ...
Actinium is a pioneer in the development of targeted radiotherapies intended to meaningfully improve patient outcomes. Actinium is advancing its lead product candidate Actimab-A, a CD33 targeting ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
CNL, Canada's premier nuclear science facility, will conduct preclinical studies combining alpha-particle radiotherapy Actinium-225 ("Ac-225") with Defence's proprietary Accum ® delivery technology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results